INTRODUCTION
============

Urinary tract infection (UTI) is one of the most frequently encountered bacterial infections presenting to hospitals and up to 60% of women will experience at least 1 episode of symptomatic UTI during their lifespan in the United States.^[@R1]^ Positive blood cultures at the time of presentation were reported among 15% to 25% of UTI episodes,^[@R2]--[@R4]^ but more than 40% of patients with complicated acute pyelonephritis developed bacteremia in Taiwan.^[@R5]^ In general, bacteremia is associated with severe sepsis or septic shock (hereafter using "critical sepsis" to stand for both severe sepsis and septic shock), and around 26% to 33% of patients with bacteremic UTI presented with critical sepsis at presentation.^[@R6],[@R7]^ Of special concerns, the case fatality rate (CFR) of patients who developed UTI concurrently with critical sepsis may be up to 30% to 50%.^[@R8]^ Facing patients developing severe acute bacterial infections, it is recommended that empirical therapy should effectively cover over 80% to 90% possible pathogens to ensure a better outcome.^[@R9]^ It has been argued that drug-resistant bacteria might play an important role in the severity of initial presentations or clinical outcomes of UTI. Some studies demonstrated that drug resistance did not influence the severity of infection at presentation.^[@R7],[@R10]^ However, other studies did disclose a positive correlation.^[@R11],[@R12]^ If drug resistance does matter, it would lead to an additional concern on the selection of empirical therapy for patients with severe UTI. The aim of this study is to compare the clinical characteristics of patients with bacteremic UTI caused by multidrug-resistant (MDR) and non-MDR *Enterobacteriaceae*, and to identify whether MDR uropathogens were one of the associated factors with critical sepsis at presentation in these patients.

MATERIALS AND METHODS
=====================

Study Design and Settings
-------------------------

This retrospective study was conducted in Chia-Yi Christian Hospital (CYCH), a 1000-bed regional teaching hospital in southern Taiwan. The list of adult patients (aged 18 years or more) receiving treatment at CYCH between January 2006 and August 2015 due to bacteremic UTI was retrieved first from the hospital\'s databank. The inclusion criteria in this study were: at least one of the following urinary tract symptoms, including dysuria, suprapubic tenderness, flank pain, or fever; bacterial growth ≧10^5^ colony-forming units (cfu)/mL in midstream urine or ≧10^3^ cfu/mL in a single catheter urine specimen; and isolation of the same *Enterobacteriaceae* from both urine and blood culture.^[@R13]^ UTI concurrently combined with other systemic infections, including pulmonary infection, pressure sores, cellulitis, enterocolitis, liver abscess, peritonitis, osteomyelitis, biliary tract infection, pelvic inflammatory disease, pulmonary tuberculosis, catheter-related infection, patients on dialysis therapy, and other diseases, were excluded. Finally, only those patients with monoclonal UTI and bacteremia caused by *Enterobacteriaceae* without other infectious sources identified by clinicians were enrolled. A part of patients (from 2006 to August 2012) enrolled by the present study has also been included in a previous study to investigate the risk factors for septic shock.^[@R14]^ In that study, the information and effect of MDR pathogens were not collected and analyzed, and also the outcome of interest was different. A standardized case report form was used to collect the following clinical information: age, gender, underlying diseases, urological history, clinical manifestations and initial laboratory data at presentation, causative microorganisms, antimicrobial resistance patterns, antibiotic treatment, length of hospital stay, and in-hospital mortality. Comorbidities were recorded according to the score proposed by Charlson et al.^[@R15]^ The severity of bacteremic UTI was assessed when the positive blood culture was also evaluated by using the Pitt bacteremia score.^[@R16]^

Definitions
-----------

Presence of 2 or more of the followings, including fever or hypothermia, tachycardia, tachypnea, and leukocytosis or leukopenia, was considered as sepsis.^[@R17]^ Severe sepsis was defined as sepsis associated with at least 1 organ dysfunctions or tissue hypoperfusion, such as renal dysfunction (serum creatinine \>2 mg/dL in patients without prior renal insufficiency or an increase of 0.5 mg/dL of basal creatinine levels in patients with chronic renal insufficiency), hematologic dysfunction (platelet count \<10^5^/μL), and central nervous system dysfunction (deterioration in consciousness level).^[@R18]^ Septic shock was defined as either systolic blood pressure ≤90 mm Hg or mean arterial pressure ≤70 mm Hg. Leukocytosis was defined as a white blood cell count ≥12 K/μL, thrombocytopenia as a platelet count ≤10^5^/μL, and a markedly elevated C-reactive protein (CRP) level as \>10 mg/dL. Infections of the ureter or kidney, including renal abscess demonstrated by renal image or acute pyelonephritis, were classified as upper UTI and others were categorized into lower UTI.^[@R19]^ History of recurrent UTI was described as one or more episode in the past prior to the current hospitalization. Empirical therapy was defined as antibiotics given before the blood culture and its susceptibility testing results were available whereas definitive therapy was defined as effective therapy prescribed according to the results of final blood cultures and susceptibility testing. Empirical therapy was further classified into 2 groups: effective empirical therapy and ineffective empirical therapy. The former was defined as empirical antibiotics prescribed being actively against the causative pathogen according to in vitro susceptibility testing; the latter was defined by empirical antibiotics being ineffectively against it. Imaging study included renal echography, intravenous pyelography, and computerized tomography scans. The study was approved by the ethics review boards of the hospital.

Microbiologic Studies
---------------------

All bacterial isolates from urine and blood samples were identified using automated Vitek version 2.0 (Biomerieux, France). The antimicrobial susceptibilities, including ampicillin/sulbactam, piperacillin/tazobactam (TZP), cefazolin, cefuroxime, cefotaxime, cefepime, ertapenem, meropenem, levofloxacin, gentamicin, amikacin, and trimethoprim/sulfamethoxazole, were determined using disk diffusion method according to the recommendation of the Clinical and Laboratory Standards Institute^[@R20]^ and the results were interpreted using the criteria suggested by Clinical and Laboratory Standards Institute.^[@R21]^ MDR strains were defined as isolates resistant to 3 or more antibiotic classes among tested antimicrobial agents according to international expert recommendations.^[@R22]^

Statistical Analysis
--------------------

Continuous variables were described as means and standard deviations, and analyzed using a Mann--Whitney *U* test. Categorical variables were expressed as frequency and proportions and compared with Chi-square test or Fisher exact test if the expected number was less than or equal to 10. All tests were 2-tailed and a *P*-value \<0.05 was considered statistically significant. Multivariate logistic regression analysis was performed using the backward stepwise method to identify the independent associated factors for critical sepsis. Variables with *P* \< 0.2 in univariate analysis were included in the multivariate model to control for confounding. Statistical analyses were performed using the SPSS 17.0 software (International Business Machines Corp., Armonk, NY).

RESULTS
=======

Study Population and Microbiological Results
--------------------------------------------

Initially, a total of 2553 patients with the diagnosis of UTI were recruited, but 377 patients among them were excluded because they had other systemic infections concurrently. Of 2176 cases with only UTI, 1561 patients without bacteremic UTI were excluded subsequently. Later 615 adult patients with bacteremic UTI were screened during the study period, and 30 of them were excluded because the isolates did not belong to *Enterobacteriaceae* family. Finally, 585 patients were enrolled in this study, and 220 (37.6%) were infected with MDR *Enterobacteriaceae* (Figure [1](#F1){ref-type="fig"}). Among these patients, around three-fourths were female and the mean ± SD of age was 69 ± 15 years (Table [1](#T1){ref-type="table"}). The 3 leading comorbidities were hypertension, diabetes mellitus, and cerebrovascular accident. Among the 408 patients undergoing image studies, 112 patients were found to have hydronephrosis. Approximately 20% of these patients developed renal dysfunction due to the UTI episodes. Also, about 20% of these patients had indwelled urinary catheter on presentation. Critical sepsis at presentation was identified in 206 (35.2%) patients: 166 with severe sepsis and 40 with septic shock. Ninety-nine (16.9%) patients were admitted to intensive care unit (ICU) because of the UTI episodes. Among all of these *Enterobacteriaceae* isolates, *Escherichia coli* were the most common microorganism (497/585, 85.0%). Other uropathogens included *Klebsiella pneumoniae* (39 patients), *Proteus mirabilis* (27), *Citrobacter* sp (8), *Enterobacter* sp (8), *Serratia marcescens* (5), and *Providencia rettgeri* (1). To sum up, the in vitro susceptibilities to ampicillin/sulbactam, TZP, cefazolin, cefuroxime, cefotaxime, cefepime, ertapenem, meropenem, levofloxacin, gentamicin, amikacin, and trimethoprim/sulfamethoxazole were 72.3%, 96.0%, 45.6%, 79.5%, 79.7%, 90.5%, 99.0%, 99.8%, 77.0%, 74.9%, 98.6%, and 51.7%, respectively. The detailed resistance patterns stratified by different microorganisms are shown in Table [2](#T2){ref-type="table"}. A total of 432 patients (75.1%; data available only in 575 patients) received effective empirical therapy, and the mean ± SD of hospital stay was 10 ± 5.79 days. Overall, the crude in-hospital mortality rate was 2.2%.

![Flow chart of bacteremic urinary tract infection included in the analysis.](medi-95-e3694-g001){#F1}
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Distribution of Uropathogens and Antimicrobial Susceptibility in Patients With Bacteremic Urinary Tract Infection Caused by *Enterobacteriaceae*

![](medi-95-e3694-g003)

Comparison of Clinical Characteristics of MDR and Non-MDR Bacteremic UTI Patients
---------------------------------------------------------------------------------

The comparison of clinical, laboratory, and microbiological variables between these 2 groups are also demonstrated in Table [1](#T1){ref-type="table"}. The mean age is not different between the 2 groups but the patients in the MDR group had a tendency toward being male gender. Higher Charlson comorbidities index score was observed in MDR group. Patients in the MDR group were also more likely to have a past history of gout, recurrent UTI, prior hospitalization, and previous invasive urologic procedure within 30 days.

As for clinical manifestations and laboratory data, more patients in the MDR group presented with consciousness change but without statistical significance (*P* = 0.088). Laboratory parameters indicating severe diseases such as leukocytosis, thrombocytopenia, and markedly elevated CRP level did not differ between these 2 groups. However, hydronephrosis, urolithiasis including renal and ureteral stone, and presence of indwelling urinary catheter were much more frequently observed in MDR patients. Furthermore, patients with MDR *Enterobacteriaceae* were more likely to develop renal dysfunction, critical sepsis (40.9% vs 31.8%, *P* = 0.025), and to be admitted to ICU. *E coli*, *K pneumoniae*, and *P. mirabilis* were the most frequently isolated causative microorganisms in both groups without significant differences between them.

Concerning treatment, significantly much smaller portion of patients in the MDR group were prescribed with effective empirical therapy (43.5% vs 93.9%, *P* \< 0.001), and the hospital stay was longer for patients of the MDR group compared with those of the non-MDR group (mean 11.20 vs 9.27 days, *P* \< 0.001). The in-hospital mortality was slightly higher in the MDR patients than the non-MDR patients without significant difference (2.7% vs 1.9%, *P* = 0.569). Among these mortality cases, 30.8% (4/13) did not receive effective empirical therapy, and all the 4 patients belonged to the MDR group (4/6 vs 0/7, *P* = 0.021).

Factors Related to Critical Sepsis in Patients With Bacteremic UTI
------------------------------------------------------------------

In order to identify whether MDR *Enterobacteriaceae* was one of the associated factors for critical sepsis in patients with bacteremic UTI, logistic regression analysis was performed using potential factors predicted by urivariate analysis (Table [3](#T3){ref-type="table"}). Age, hypertension, liver cirrhosis, indwelling urinary catheter, history of prior admission within 1 year, upper UTI, and MDR *Enterobacteriaceae* were all associated with critical sepsis in univariate analysis (Table [3](#T3){ref-type="table"}). Multivariate analysis revealed that liver cirrhosis (OR 2.868; 95% CI 1.439--5.716, *P* = 0.003), indwelling urinary catheter (OR 1.936; 95% CI 1.238--3.027, P = 0.004), and MDR *Enterobacteriaceae* (OR 1.447; 95% CI 1.002--2.090, *P* = 0.049) were significant predictors for critical sepsis.
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Results of the Logistic Regression Model for Factors Related to Critical Sepsis
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DISCUSSION
==========

This study was undertaken to compare the clinical characteristics between patients with bacteremic UTI caused by MDR or non-MDR *Enterobacteriaceae*, and investigate the predictors for critical sepsis on presentation among these patients. We found that patients in the MDR group have distinct clinical manifestation in gender, comorbidities, past histories, urinary tract abnormalities and were associated with worse clinical course, including development of critical sepsis, ICU admission, longer hospital stay, and higher in-hospital mortality. Liver cirrhosis, presence of indwelling urinary catheter, and MDR *Enterobacteriaceae* were independently associated with critical sepsis at admission.

Most prior studies^[@R23],[@R24]^ demonstrated that the male gender was more frequently observed in patients with infection caused by drug-resistant pathogens, which supported our findings. Complicated UTIs, including presence of hydronephrosis, urinary tract abnormalities, and need for indwelling urinary catheter due to obstructive uropathy, have been shown to be associated with high drug resistance rates,^[@R25],[@R26]^ which were also demonstrated in our study. Hence, detailed obtainment of urologic history, especially for male patients, would alert clinicians about the possibilities of drug-resistant infections. In terms of clinical features, 1 prior study showed shock on presentation among patients with bloodstream infections was significantly more common in those caused by drug-resistant bacteria.^[@R27]^ Our report also found that patients in the MDR group had a much higher Charlson comorbidities index score and a more severe diseases on initial presentation. Because of more complicated underlying and severe clinical conditions, tendency to develop renal dysfunction and critical sepsis in patients of MDR group was anticipated. Therefore, it seems to be reasonable that ICU admission was also more common in patients with drug-resistant uropathogens, just as reported by Oliveira et al.^[@R23]^ Therefore, for those patients with complex underlying diseases and serious clinical manifestations, clinicians should cautiously consider to use an empirical therapy with coverage of MDR pathogens.

In our study, the major 3 empirical antimicrobial agents prescribed were 1st- or 2nd-generation cephalosporins (39.5%), fluoroquinolones (27.9%), and 3rd-generation cephalosporins (23.6%). Because the susceptible rates of the MDR *Enterobacteriaceae* in this study to antibiotics belonging to the 3 above-mentioned classes were much less than non-MDR *Enterobacteriaceae*, the proportion of patients in MDR group receiving effective empirical therapy was therefore much smaller compared with that in non-MDR group. Such a finding has been demonstrated by several other reports.^[@R23],[@R28]^ Good understanding of local epidemiology might be helpful for physicians to administer adequate antibiotics initially, even in the MDR group. The significant difference in hospital stay between the MDR group and the non-MDR group has also been disclosed by previous comparable observations,^[@R23],[@R24],[@R29]^ which might raise the medical costs. The crude in-hospital mortality measured in our study was lower than several prior reports.^[@R6],[@R7]^ This could be due to the fact that less patients presenting with septic shock were enrolled in the present study (7% vs 15%--26%). More importantly, higher in-hospital mortality rate was noted in patients with bacteremic UTI caused by MDR pathogens. These might be partly attributed to that more patients in MDR group received inadequate empirical antibiotic therapy, as suggested by several prior studies.^[@R23],[@R24],[@R28],[@R29]^ Thus, identifying the associated factors of getting MDR pathogens infections and prescribing appropriate empirical antimicrobial agents is critical in reducing hospitalization days and mortality rates.

Several important predictors for critical sepsis at presentation among patients with bacteremic UTI had been identified in our study. These included liver cirrhosis, indwelling urinary catheter, and MDR *Enterobacteriaceae*. Lee et al^[@R6]^ demonstrated that liver cirrhosis was an independent risk factor for the occurrence of septic shock among patients with bacteremic acute pyelonephritis, which is in agreement with our findings. It is well-understood that impairment of humoral and cell-mediated immunity often occurred in patients with liver cirrhosis.^[@R30]^ Thus, much more severe clinical manifestations were anticipated in cirrhotic patients with bacteremic UTI. Moreover, the presence of indwelling urinary catheter might imply a severe underlying disease (Charlson comorbidity index score, 3.13 ± 2.28 vs 1.97 ± 1.85, *P* \< 0.001) or poor general condition.^[@R7],[@R31]^ Therefore, it was intuitive that presence of indwelling urinary catheter could be an independent factor associated with critical sepsis in bacteremic UTI. In other words, when those cirrhotic patients with indwelling urinary catheters were admitted due to UTI, it is important to consider following the guidelines of surviving sepsis campaign, as they are at risk of developing critical sepsis.

The debate whether MDR pathogens had effect on clinical manifestations upon presentation had been noted for a time. Ortega et al^[@R27]^ have demonstrated that shock on presentation was significantly more frequently noted in cefotaxime-resistant *Klebsiella* bloodstream infection than cefotaxime-susceptible isolates. Notwithstanding, 1 prospective, large hospitalized cohort study conducted in Spain showed a different result.^[@R7]^ The reasons why such a difference occurred between the 2 studies might be due to different study population and different criteria for enrollment. Ortega et al also proposed that drug-resistant pathogens might be more virulent.^[@R27]^ However, some authors demonstrated that the expression of drug resistance in some bacterial pathogens may be associated with extra biological costs, leading to the attenuation of their virulence.^[@R32]^ In addition, the *P* value of the association between MDR pathogens and critical sepsis revealed by our present study was only of borderline significance (0.049) even in the multivariate model. Also, an association between poor host factors and MDR pathogens was found in the current study, and relatively critical status upon presentation may be affected by these host or environmental factors. Therefore, further studies are needed to conclude that MDR pathogens infections are one of the significant predictors for critical sepsis. However, as critical sepsis at presentation might be a surrogate marker for contracting MDR pathogens by current available evidence, clinicians should consider prescribing more broad-spectrum antimicrobial agents, such as TZP, carbapenems, and 4th-generation cephalosporins, as initial therapy for UTI patients with severe sepsis.

There were some limitations in our study. First, clinical information was collected retrospectively and several biases as well as missing data would be unavoidable. Second, this study was performed only in 1 single institution and hence generalization should be handled carefully. Third, we did not analyze virulence genes or phylogenetic groups of these *Enterobacteriaceae*; therefore, the correlation of virulence factors of MDR uropathogens and host clinical presentations should be further investigated. Fourth, because of the low mortality rate, multivariate analysis to identify factors associated with mortality could not be conducted. Finally, previous antibiotic exposure, which would have a great impact on subsequent acquirement of MDR pathogens infection or colonization, was not evaluated in the present study. Nonetheless, it was usually difficult to collect information about prior antibiotics exposure from patients going to emergency department for acute infectious diseases. It will be helpful for clinical physicians in decision-making about choices of antibiotics if there was any surrogate marker that could be easily collected or identified to indicate the risk of presence of MDR pathogens. In this way, disease severity, as disclosed by the present study, would be a useful parameter to predict whether MDR pathogens were the etiology or not.

In conclusion, different clinical characteristics could be found between the MDR group and the non-MDR group, and the former had more severe disease at presentation, including a much higher frequency of critical sepsis, ICU admission, longer hospitalization, and in-hospital mortality. Patients in MDR group were independently associated with critical sepsis at presentation. When we treated patients with bacteremic UTI conforming with the criteria of critical sepsis at initial presentation, empirical prescription with more broad-spectrum antibiotics covering potential drug resistance pattern, such as TZP, carbapenems, or 4th-generation cephalosporins, should be considered.

Abbreviations: ICU = intensive care unit, MDR = multidrug-resistant, TZP = piperacillin/tazobactam, UTI = urinary tract infection.
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